Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert D'Haens

Showing results (61-70 of 269) with videos related to

Pageof 27
Sort By:
The American Journal of Gastroenterology|March 29, 2008
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trialStefanie Kulnigg, Simeon Stoinov, Vladimir Simanenkov, et al.
Journal of Crohn'S & Colitis|May 1, 2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease RecurrenceMarc Ferrante, Konstantinos Papamichael, Dana Duricova, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2022
Intestinal ultrasound detects an increased diameter and submucosal layer thickness in the appendix of patients with ulcerative colitis compared to healthy controls - a prospective cohort studyMaud A Reijntjes, Floris A E de Voogd, Willem A Bemelman, et al.
Clinics and Research in Hepatology and Gastroenterology|May 16, 2024
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel diseaseSeverine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases|October 6, 2023
Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential OverdiagnosesMaud Reijntjes, Djuna de Jong, Elise Wessels, et al.
The American Journal of Gastroenterology|July 18, 2023
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 TrialJean-Frederic Colombel, Geert D'Haens, Peter Irving, et al.
BMJ Open Gastroenterology|May 31, 2016
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort studySilvio Danese, Ailsa Hart, Axel Dignass, et al.
Clinical and Translational Gastroenterology|January 10, 2025
Vidofludimus Calcium in Patients With Moderate-to-Severe Ulcerative Colitis: A Randomized, Placebo-Controlled, Phase 2 TrialGeert D'Haens, Kalina Grivcheva Stardelova, Edite Sadiku, et al.
The American Journal of Gastroenterology|July 18, 2023
P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North StudyBruce Sands, Marc Pondel, Michael Silver, et al.
Gastroenterology|May 16, 2006
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrenceMarc Ferrante, Gert de Hertogh, Tibor Hlavaty, et al.
Pageof 27

Showing results (61-70 of 269) with videos related to

Sort By:
Pageof 27
The American Journal of Gastroenterology|March 29, 2008
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (FERINJECT) randomized controlled trialStefanie Kulnigg, Simeon Stoinov, Vladimir Simanenkov, et al.
Journal of Crohn'S & Colitis|May 1, 2015
Systematic versus Endoscopy-driven Treatment with Azathioprine to Prevent Postoperative Ileal Crohn's Disease RecurrenceMarc Ferrante, Konstantinos Papamichael, Dana Duricova, et al.
Alimentary Pharmacology & Therapeutics|November 2, 2022
Intestinal ultrasound detects an increased diameter and submucosal layer thickness in the appendix of patients with ulcerative colitis compared to healthy controls - a prospective cohort studyMaud A Reijntjes, Floris A E de Voogd, Willem A Bemelman, et al.
Clinics and Research in Hepatology and Gastroenterology|May 16, 2024
Forecasted infliximab concentrations during induction predict time to remission and sustained disease control of inflammatory bowel diseaseSeverine Vermeire, Marla C Dubinsky, Shervin Rabizadeh, et al.
Inflammatory Bowel Diseases|October 6, 2023
Crohn's Disease of the Ileoanal Pouch: A High Rate of Potential OverdiagnosesMaud Reijntjes, Djuna de Jong, Elise Wessels, et al.
The American Journal of Gastroenterology|July 18, 2023
P037 Effect of Ozanimod Treatment and Discontinuation on Absolute Lymphocyte Count in Moderate-to-Severe Ulcerative Colitis: Results from a Phase 3 TrialJean-Frederic Colombel, Geert D'Haens, Peter Irving, et al.
BMJ Open Gastroenterology|May 31, 2016
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort studySilvio Danese, Ailsa Hart, Axel Dignass, et al.
Clinical and Translational Gastroenterology|January 10, 2025
Vidofludimus Calcium in Patients With Moderate-to-Severe Ulcerative Colitis: A Randomized, Placebo-Controlled, Phase 2 TrialGeert D'Haens, Kalina Grivcheva Stardelova, Edite Sadiku, et al.
The American Journal of Gastroenterology|July 18, 2023
P031 Impact of Prior Biologic Exposure on Response to Ozanimod for Moderate-to-Severe Ulcerative Colitis in the Phase 3 True North StudyBruce Sands, Marc Pondel, Michael Silver, et al.
Gastroenterology|May 16, 2006
The value of myenteric plexitis to predict early postoperative Crohn's disease recurrenceMarc Ferrante, Gert de Hertogh, Tibor Hlavaty, et al.
Pageof 27